| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.081 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |